After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE S&P Capital IQ
Know which stocks are interest-rate sensitive and which don't care, says Jim Cramer.
Pharmaceutical giant Allergan looks poised to have a great year in 2017.
This sector is one of the few areas of the market where you'll find myriad compelling values.
Experts say unflattering comparisons of deal values this year versus last year distort the longer term constructive trends.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.